New diabetes clinical trial: Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes | | Published on: February 10, 2020 at 07:00PM Condition: Latent Autoimmune Diabetes in Adults Interventions: Drug: recombinant human glutamic acid dehydrogenase (rhGAD65), formulated in aluminium hydrogel; Drug: Vitamin D Sponsors: Norwegian University of Science and Technology; St. Olavs Hospital; Diamyd Medical AB; Karolinska University Hospital; Linkoeping University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04262479?term=diabetes&sfpd_d=14 February 10, 2020 at 03:04PM via ClinicalTrials.gov |
New diabetes clinical trial: A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes | | |
New diabetes clinical trial: A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY) | | |
New diabetes clinical trial: Sedentary Behavior in Older Women With and Without Type 2 Diabetes | | |
New diabetes clinical trial: Human Milk: Understanding the Mechanisms Linked to the Prevention of Obesity and Diabetes in Children Exposed in Utero to Gestational Diabetes | | |
New diabetes clinical trial: Skills for Change: Nutrition Education Program for Emirati Adults With Type 2 Diabetes | | |
New diabetes clinical trial: Project MiNT: Assessing the Impact of Food & Video-Based Nutrition Education on Patients With Poorly Controlled Diabetes | | |
New diabetes clinical trial: Precision Nutrition Counseling in Type 2 Diabetes Patients | | |
New diabetes clinical trial: Stories for Change: Digital Storytelling for Diabetes Self-Management Among Somali Adults | | |
New diabetes clinical trial: Effectiveness of Dietitian-led Dietary Approach to Management of Diabetes (DIAM-D) | | |
New diabetes clinical trial: An Alternative Approach to Improve Hyperglycemia Among Type 2 Diabetes Patients | | |
New diabetes clinical trial: An Alternative Approach to Improve Hyperglycemia Among Type 2 Diabetes Patients | | |
Няма коментари:
Публикуване на коментар